NCT06370442View on ClinicalTrials.gov

Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

September 1, 2025

Conditions

Altered Mental Status

Interventions

DRUG

Dexmedetomidine

Intranasal dexmedetomidine, 100mcg

DRUG

Lorazepam

0.5mg IV

DRUG

Haloperidol

0.5mg IV

All Listed Sponsors

lead

State University of New York - Upstate Medical University

OTHER